Loading...
XASXOIL
Market cap85mUSD
Dec 27, Last price  
0.17AUD
1D
0.00%
1Q
-13.16%
Jan 2017
175.00%
Name

Optiscan Imaging Ltd

Chart & Performance

D1W1MN
XASX:OIL chart
P/E
—
P/S
119.27
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
13.21%
Rev. gr., 5y
-2.66%
Revenues
1m
-31.22%
1,066,9623,232,0155,707,5361,840,6492,887,6261,233,7481,776,954381,7911,303,34584,67752,592309,6971,333,2632,967,3371,322,1441,190,712889,5261,013,0391,680,1801,155,604
Net income
-6m
L+39.27%
-5,830,434-3,936,760-2,139,481-4,984,340-6,413,370-1,650,79914,405-2,502,450-643,950-1,417,712-1,395,399-1,337,056-2,942,925-2,035,327-2,344,119-1,765,353-2,126,695-4,233,037-4,351,500-6,060,496
CFO
-6m
L+82.22%
-4,001,422-4,810,970-1,882,270-4,094,939-3,189,129-1,227,864-468,579-793,545-1,193,270-683,392-1,459,644-509,246-3,412,811-2,323,792-1,420,797-1,396,563-2,126,309-3,833,578-3,152,494-5,744,450
Earnings
Feb 21, 2025

Profile

Optiscan Imaging Limited develops and commercializes confocal microscopes for clinical and pre-clinical applications in Australia, Germany, and Internationally. It offers FIVE2 (ViewnVivo) system, a miniaturized confocal endomicroscopes use for clinical, translational, pre-clinical, and other research. The company also engages in the development of InVivage device for use in cancer screening and surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
URL
https://www.optiscan.com/
IPO date
Aug 08, 1997
Employees
8
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
1,156
-31.22%
1,680
65.86%
1,013
13.89%
Cost of revenue
9,003
6,968
6,481
Unusual Expense (Income)
NOPBT
(7,848)
(5,288)
(5,468)
NOPBT Margin
Operating Taxes
(738)
(942)
Tax Rate
NOPAT
(7,848)
(4,550)
(4,526)
Net income
(6,060)
39.27%
(4,352)
2.80%
(4,233)
99.04%
Dividends
Dividend yield
Proceeds from repurchase of equity
16,618
41
45
BB yield
-8.59%
-0.08%
-0.06%
Debt
Debt current
221
232
176
Long-term debt
181
361
745
Deferred revenue
Other long-term liabilities
8
24
19
Net debt
(10,831)
(282)
(3,660)
Cash flow
Cash from operating activities
(5,744)
(3,152)
(3,834)
CAPEX
(87)
(127)
(124)
Cash from investing activities
(5,233)
(127)
(124)
Cash from financing activities
16,207
(374)
45
FCF
(8,400)
(4,128)
(4,704)
Balance
Cash
11,232
875
4,529
Long term investments
53
Excess cash
11,174
791
4,531
Stockholders' equity
13,867
3,044
6,592
Invested Capital
2,922
2,689
2,629
ROIC
ROCE
EV
Common stock shares outstanding
822,940
623,291
631,124
Price
0.24
193.75%
0.08
-27.27%
0.11
-52.17%
Market cap
193,391
287.84%
49,863
-28.18%
69,424
-48.24%
EV
182,560
49,581
65,763
EBITDA
(7,280)
(4,909)
(5,228)
EV/EBITDA
Interest
24
32
32
Interest/NOPBT